Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 8, 2001, Pages 3845-3852

  Clasey, Jody L ^a   Weltman, Arthur ^a   Patrie, Jim ^a   Weltman, Judy Y ^a   Pezzoli, Suzan ^a   Bouchard, Claude ^b   Thorner, Michael O ^a   Hartman, Mark L ^a,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GROWTH HORMONE; INSULIN; OXYGEN; SOMATOMEDIN C; TESTOSTERONE;

ADULT; AGE; AGED; ARTICLE; BODY FAT; CHEMOLUMINESCENCE; COMPUTER ASSISTED TOMOGRAPHY; DEMOGRAPHY; DIET RESTRICTION; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE TEST; FEMALE; GROWTH HORMONE RELEASE; HUMAN; INSULIN BLOOD LEVEL; MALE; MEASUREMENT; MODEL; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEX DIFFERENCE;

EID: 0034887335     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.8.7731     Document Type: Article

References (50)

1. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human
2. Peptidomimetic regulation of growth hormone secretion
3. Ghrelin is a growth-hormone releasing acylated peptide from stomach
4. The influence of age on the 24-h integrated concentrations of growth hormone in normal individuals
5. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review
6. Genetic and nongenetic determinants of regional fat distribution
7. Regional distribution of body fat, plasma lipoproteins and cardiovascular disease
8. Abdominal adiposity rather than age and sex predict mass and regularity of GH secretion in healthy adults
9. Body fat distribution in pre- and post-menopausal women: Metabolic and anthropometric variable and their inter-relationships
10. The influence of anatomical boundaries, age and sex on the assessment of abdominal visceral fat
11. Body composition by DXA in older adults: Accuracy and influence of scan mode
12. Pulsatile growth hormone secretion in older persons is enhanced by fasting without relationship to sleep stages
13. Enhanced sensitivity growth hormone chemiluminescence assay reveals lower postglucose nadir GH concentration in men and women
14. Radioimmunoassay of insulin
15. Validity of body composition assessment in younger and older males and females
16. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory burst and the half-life of endogenous GH in healthy men
17. Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay
18. Relationship between age, percentage body fatness, fitness, and 24-hour growth hormone release in healthy young adults: Effects of gender
19. Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults
20. The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone
21. Age changes in body composition revealed by computed tomography
22. Abdominal fat distribution and metabolic risk factors: Effects of race
23. Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women
24. Racial differences in amounts of visceral adipose tissue in young adults: The CARDIA (Coronary Artery Risk Development in Young Adults) Study
25. Greater secretion of growth hormone in black than in white men: Possible factor in greater bone mineral density - A Clinical Research Center study
26. Demonstration of a lack of racial difference in secretion of growth hormone despite a racial difference in bone mineral density in premenopausal women - A Clinical Research Center study
27. Visceral obesity in men: Association with glucose tolerance, plasma insulin, and lipoprotein levels
28. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH
29. Role of abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women
30. 'Portal' adipose tissue as a generator of risk factors for cardiovascular disease and diabetes
31. Glucose metabolism in identical twins discordant for obesity. The critical role of visceral fat
32. A low-dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans
33. Effects of aging on the sensitivity of growth hormone secretion to insulin-like growth factor (IGF)-I negative feedback
34. Recovery of growth hormone release from suppression by exogenous insulin-like growth factor (IGF)-I: Evidence for a suppressive action of free rather than bound IGF-I
35. Nutritional regulation of IGF-I and IGF binding proteins
36. Free insulin-like growth factors in human obesity
37. Somatomedin-C levels in healthy young and old men: Relationship to peak and 24-hour integrated levels of growth hormone
38. Serum levels of insulin-like growth factor-1 in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects
39. The effect of intensive endurance exercise training on body fat distribution in young and older men
40. Effects of endurance training on glucose tolerance and plasma lipids in older men and women
41. Effects of sex and age on the 24-h profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations
42. An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women
43. Pulsatile growth hormone release in normal women during the menstrual cycle
44. Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: Effect of physiological estrogen replacement
45. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women
46. Both oral and transdermal estrogen increase growth hormone release in postmenopausal women - A Clinical Research Center study